Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

Terns Pharmaceuticals (TERN)

Terns Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TERN
DateTimeSourceHeadlineSymbolCompany
08/05/202421:05GlobeNewswire Inc.Terns Pharmaceuticals Announces Leadership ChangesNASDAQ:TERNTerns Pharmaceuticals Inc
07/05/202421:05GlobeNewswire Inc.Terns Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference 2024NASDAQ:TERNTerns Pharmaceuticals Inc
03/05/202421:05GlobeNewswire Inc.Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:TERNTerns Pharmaceuticals Inc
29/04/202421:05GlobeNewswire Inc.Terns Pharmaceuticals Announces Data from Ongoing Phase 1 Pharmacokinetic Study of Allosteric BCR-ABL Inhibitor TERN-701 in Adult Healthy Volunteers and Highlights Potential for Competitive DifferentiationNASDAQ:TERNTerns Pharmaceuticals Inc
10/04/202421:05GlobeNewswire Inc.Terns Pharmaceuticals Appoints Melita Sun Jung as Chief Business OfficerNASDAQ:TERNTerns Pharmaceuticals Inc
14/03/202420:05GlobeNewswire Inc.Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate UpdatesNASDAQ:TERNTerns Pharmaceuticals Inc
11/03/202420:05GlobeNewswire Inc.Terns Pharmaceuticals Announces Orphan Drug Designation Granted to TERN-701 for the Treatment of Chronic Myeloid LeukemiaNASDAQ:TERNTerns Pharmaceuticals Inc
07/03/202421:05GlobeNewswire Inc.Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:TERNTerns Pharmaceuticals Inc
05/03/202423:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TERNTerns Pharmaceuticals Inc
27/02/202421:05GlobeNewswire Inc.Terns Pharmaceuticals to Participate in Upcoming March Investor ConferencesNASDAQ:TERNTerns Pharmaceuticals Inc
15/02/202423:02Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TERNTerns Pharmaceuticals Inc
14/02/202413:57Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TERNTerns Pharmaceuticals Inc
07/02/202421:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TERNTerns Pharmaceuticals Inc
07/02/202421:05GlobeNewswire Inc.Terns Pharmaceuticals Reports Inducement Grants to New Chief Executive Officer Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:TERNTerns Pharmaceuticals Inc
07/02/202413:05GlobeNewswire Inc.Terns Pharmaceuticals Appoints Amy Burroughs as Chief Executive OfficerNASDAQ:TERNTerns Pharmaceuticals Inc
02/02/202421:05GlobeNewswire Inc.Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:TERNTerns Pharmaceuticals Inc
26/01/202400:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TERNTerns Pharmaceuticals Inc
04/01/202421:05GlobeNewswire Inc.Terns Pharmaceuticals to Highlight 2024 Priorities and Clinical Milestones at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:TERNTerns Pharmaceuticals Inc
03/01/202421:05GlobeNewswire Inc.Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:TERNTerns Pharmaceuticals Inc
29/11/202321:05GlobeNewswire Inc.Terns Pharmaceuticals to Present at the JMP Securities Hematology and Oncology SummitNASDAQ:TERNTerns Pharmaceuticals Inc
27/11/202321:05GlobeNewswire Inc.Terns Pharmaceuticals Mourns the Loss of Senthil Sundaram, Former Chief Executive OfficerNASDAQ:TERNTerns Pharmaceuticals Inc
14/11/202313:05GlobeNewswire Inc.Terns Pharmaceuticals Reports Third Quarter 2023 Financial Results and Corporate UpdatesNASDAQ:TERNTerns Pharmaceuticals Inc
13/11/202313:05GlobeNewswire Inc.Terns Pharmaceuticals Presents Late-Breaking Data from Phase 2a DUET Trial of THR-β Agonist TERN-501 in NASH at AASLD The Liver Meeting® 2023NASDAQ:TERNTerns Pharmaceuticals Inc
09/11/202313:05GlobeNewswire Inc.Terns Pharmaceuticals to Participate in Upcoming November Investor ConferencesNASDAQ:TERNTerns Pharmaceuticals Inc
03/11/202320:05GlobeNewswire Inc.Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:TERNTerns Pharmaceuticals Inc
02/11/202320:05GlobeNewswire Inc.Terns Pharmaceuticals Announces First Participant Dosed in Phase 1 Clinical Trial of TERN-601 Oral GLP-1 Receptor Agonist for Treatment of ObesityNASDAQ:TERNTerns Pharmaceuticals Inc
19/10/202321:05GlobeNewswire Inc.Terns Pharmaceuticals to Participate in Upcoming Investor ConferencesNASDAQ:TERNTerns Pharmaceuticals Inc
16/10/202313:05GlobeNewswire Inc.Terns Pharmaceuticals Announces Global Phase 1 Clinical Trial Design of TERN-701 for the Treatment of Chronic Myeloid LeukemiaNASDAQ:TERNTerns Pharmaceuticals Inc
10/10/202321:33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TERNTerns Pharmaceuticals Inc
03/10/202321:05GlobeNewswire Inc.Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:TERNTerns Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:TERN

Your Recent History

Delayed Upgrade Clock